Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion type Assertion NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_head.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion description "[Persistent production of IFN-?, the most abundant subtype measured in these patients, is an important feature of the immunopathogenesis of lupus and has stimulated current efforts to develop and test therapeutics that either block IFN-I or its receptor directly or target components of the IFN-I pathway involved in induction of or response to IFN-I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_provenance.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion evidence source_evidence_literature NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_provenance.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion SIO_000772 25468480 NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_provenance.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion wasDerivedFrom befree-2016 NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_provenance.
- NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_assertion wasGeneratedBy ECO_0000203 NP1244276.RA81pUbHxpYyKBn9p1vGEPsn_M8_k1_40VHXMRyZC1AnE130_provenance.